Tae-Beom Kim

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

Yong Fang, Daniel J. McGrail, Chaoyang Sun et al. · Cancer Cell · 2019 · 241 citations · Full text

Medicine, Pharmacology, Chemotherapy +8

Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma

Tyler J. Moss, Yuan Qi, Xi Liu et al. · European Urology · 2017 · 224 citations

Medicine, Genetics, Molecular Genetics +14

Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer

Funda Meric‐Bernstam, Xiaofeng Zheng, Maryam Shariati et al. · JCO Precision Oncology · 2018 · 62 citations · Full text

Medicine, Genetics, Oncology +17

Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma

Roberto Ruiz‐Cordero, Priya Rao, Lerong Li et al. · Modern Pathology · 2019 · 54 citations · Full text

Medicine, Oncology, Pathology +12

Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options

Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju et al. · Oncotarget · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15